William K. Harrington, United States Trustee, Region 2, Applicant v. Purdue Pharma L.P., et al.
-
August 14, 2023
3rd-Party Releases In Ch. 11 May Die At Supreme Court
Now that the U.S. Supreme Court has agreed to look at the nonconsensual liability releases against the Sackler family in Purdue Pharma's Chapter 11 plan, bankruptcy experts say the current set of justices, with their textualist bent, could put an end to a tool practitioners have used for decades to get to resolutions in bankruptcy.
-
August 10, 2023
Justices Halt Purdue Ch. 11 Plan Over Sackler Releases
The U.S. Supreme Court on Thursday granted the U.S. Trustee's Office's request to pause Purdue Pharma LP's Chapter 11 plan, agreeing that the stay application should be treated as a writ of certiorari and asking the parties to explain whether the courts can approve a plan that extinguishes third-party claims against the Sackler family.
-
August 04, 2023
Purdue Pharma Asks Justices To Reject Ch. 11 Challenge
A key target of U.S. opioid litigation has asked the U.S. Supreme Court to allow its bankruptcy restructuring plan to proceed, arguing that a U.S. trustee's stay request is unnecessary for several reasons, including the plan's timeline, its broad support and the trustee's purported lack of standing.
-
July 28, 2023
US Trustee Asks Supreme Court To Pause Purdue Ch. 11 Plan
The Office of the U.S. Trustee on Friday asked the U.S. Supreme Court to hit pause on a circuit decision allowing opioid maker Purdue Pharma's Chapter 11 plan to go forward, saying the high court should first decide if the company's former owners should be allowed to escape opioid liability.